U.S. market Closed. Opens in 1 hour 43 minutes

CLOV | Clover Health Investments, Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue2.03B3.48B1.47B672.89M462.27M281.02M
Cost of Revenue1.78B3.45B1.55B590.47M449.70MN/A
Gross Profit257.33M22.73M-79.18M82.42M12.56M281.02M
Operating Expenses465.87M393.66M557.81M175.13M195.76M476.00M
Selling, General & Admin444.73M486.64M445.75M191.70M187.33M187.28M
Research & DevelopmentN/AN/AN/AN/AN/AN/A
Other Operating Expenses21.15M-92.98M112.06M-16.57M8.44MN/A
Operating Income-208.54M-370.92M-636.99M-92.71M-183.20M-185.80M
Other Expenses / Income-4.82M32.08M49.24M-43.69M-180.54M-16.13M
Before Tax Income-213.36M-338.84M-587.76M-91.58M-363.74M-201.93M
Income Tax ExpensesN/A-33.44M16.91M57.11M39.07M-16.13M
Net Income-213.36M-305.40M-604.67M-148.69M-402.81M-201.93M
Interest Expenses7.00K1.36M16.91M57.11M39.07MN/A
Basic Shares Outstanding482.18M476.24M412.92M88.69M103.50M42.01M
Diluted Shares Outstanding482.18M476.24M412.92M88.69M103.50M42.01M
EBITDA-210.84M-337.02M-569.60M-78.73M-182.65M-16.13M
EBITDA Margin-10.37%-9.69%-38.70%-11.70%-39.51%-5.74%
EBIT-213.35M-337.48M-570.85M-34.47M-324.67M-218.06M
EBIT Margin-10.49%-9.71%-38.78%-5.12%-70.23%-77.59%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙